Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Phenomenex to Present Four Workshops at Pittcon 2013

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
Workshops will cover proteins, environmental contaminants, oligonucleotide therapeutics and core-shell technology.

“Survey of Recent Advances in Protein Analysis” will be presented on Monday, March 18 at 8:00 a.m. in Room 1268. Speakers include industry experts from Amgen, Genentech, AB SCIEX and Phenomenex. Panelists will discuss current challenges and assay requirements as well as how they are integrating new technologies in chromatography and mass spectrometry for faster and more accurate protein analysis.

“Emerging Environmental Contaminants:  Methodologies and Practices for Meeting New Performance Requirements” will be presented on Wednesday, March 20 at 8:00 a.m. in Room 1680. Scheduled panelists are from the EPA, TestAmerica, Horizon Technology, Phenova Certified Reference Materials and Phenomenex. Topics will include new testing requirements as well as information on how to achieve the highest efficiencies plus insight on the latest instrumentation in LC/MS/MS, automated sample preparation and GC/HRMS. This workshop will also cover proficiency testing and ways to optimize methods to maintain accreditation.

“New Advances in the Analysis of Oligonucleotide Therapeutics” will be presented on Wednesday, March 20 at 2:00 p.m. in Room 1268. Panelists will include experts from Merck, Novatia, AB SCIEX and Phenomenex. In this workshop, researchers from the growing field of therapeutic product development will discuss new analytical methods as well as increasing demands for the identification and quantitation of low-level genotoxic impurities from biological fluids.

“The Present and Future of Core-Shell Column Technology” will be presented on Thursday, March 21 at 8:00 a.m. in Room 2300. The panel will include experts from The Pennsylvania State University, Abbot Laboratories, Merck, Agilent, Advanced Materials Technology and Phenomenex. In this session industry experts will discuss the benefits they are realizing from using core-shell column technology in their laboratories. The workshop will also cover the latest methods and techniques that enable researchers to get the most from core-shell technology.

Phenomenex, celebrating its 30th anniversary in 2012, is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Novel Proteins Linked to Huntington's Disease
University of Florida Health researchers have made a new discovery about Huntington's disease, showing that the gene that causes the fatal disorder makes an unexpected "cocktail" of mutant proteins that accumulate in the brain.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos